Insulin secretion and insulin-producing tumors

References

• Gerich JE, Charles MA, Grodsky GM. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J. Clin. Invest.54(4), 833–841 (1974).
   PubMedGoogle Scholar
• Dean PM, Matthews EK. Electrical activity in pancreatic islet cells. Nature219(5152), 389–390 (1968).
   PubMed Web of Science ®Google Scholar
• Dean PM, Matthews EK. Glucose-induced electrical activity in pancreatic islet cells. J. Physiol.210(2), 255–264 (1970).
   PubMed Web of Science ®Google Scholar
• Cook DL, Hales CN. Intracellular ATP directly blocks K+ channels in pancreatic β-cells. Nature311(5983), 271–273 (1984).
   PubMed Web of Science ®Google Scholar
• Ashcroft FM, Harrison DE, Ashcroft SJ. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature312(5993), 446–448 (1984).
   PubMed Web of Science ®Google Scholar
• Schwanstecher M, Loser S, Chudziak F, Panten U. Identification of a 38-kDa high affinity sulfonylurea-binding peptide in insulin-secreting cells and cerebral cortex. J. Biol. Chem.269(27), 17768–17771 (1994).
   PubMedGoogle Scholar
• Clement JP 4th, Kunjilwar K, Gonzalez G et al. Association and stoichiometry of K(ATP) channel subunits. Neuron18(5), 827–838 (1997).
   PubMed Web of Science ®Google Scholar
• Ohara-Imaizumi M, Nakamichi Y, Nishiwaki C, Nagamatsu S. Transduction of MIN6 β cells with TAT-syntaxin SNARE motif inhibits insulin exocytosis in biphasic insulin release in a distinct mechanism analyzed by evanescent wave microscopy J. Biol. Chem.277(52), 50805–50811 (2002).
   PubMedGoogle Scholar
• Ohara-Imaizumi M, Nishiwaki C, Kikuta T, Nagai S, Nakamichi Y, Nagamatsu S. TIRF imaging of docking and fusion of single insulin granule motion in primary rat pancreatic β-cells: different behaviour of granule motion between normal and Goto–Kakizaki diabetic rat β-cells. Biochem. J.381(Pt 1), 13–18 (2004).
   PubMedGoogle Scholar
• Pouli AE, Emmanouilidou E, Zhao C, Wasmeier C, Hutton JC, Rutter GA. Secretory-granule dynamics visualized in vivo with a phogrin-green fluorescent protein chimaera. Biochem. J.333 (Pt 1), 193–199 (1998).
   PubMedGoogle Scholar
• Varadi A, Ainscow EK, Allan VJ, Rutter GA. Involvement of conventional kinesin in glucose-stimulated secretory granule movements and exocytosis in clonal pancreatic β-cells. J. Cell. Sci.115(Pt 21), 4177–4189 (2002).
   PubMedGoogle Scholar
• Henquin JC. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes49(11), 1751–1760 (2000).
   PubMed Web of Science ®Google Scholar
• Thorens B, Sarkar HK, Kaback HR, Lodish HF. Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and β-pancreatic islet cells. Cell55(2), 281–290 (1988).
   PubMed Web of Science ®Google Scholar
• Matschinsky FM. Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cells and hepatocytes. Diabetes39(6), 647–652 (1990).
   PubMed Web of Science ®Google Scholar
• Barg S, Eliasson L, Renstrom E, Rorsman P. A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse β-cells. Diabetes51(Suppl. 1), S74–S82 (2002).
   Google Scholar
• Dean PM. Ultrastructural morphometry of the pancreatic-cell. Diabetologia9(2), 115–119 (1973).
   PubMedGoogle Scholar
• Pedersen MG, Sherman A. Newcomer insulin secretory granules as a highly calcium-sensitive pool. Proc. Natl Acad. Sci. USA106(18), 7432–7436 (2009).
   PubMed Web of Science ®Google Scholar
• Lu D, Mulder H, Zhao P et al. 13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS). Proc. Natl Acad. Sci. USA99(5), 2708–2713 (2002).
   PubMedGoogle Scholar
• Maechler P, Wollheim CB. Mitochondrial glutamate acts as a messenger in glucose-induced insulin exocytosis. Nature402(6762), 685–689 (1999).
   PubMed Web of Science ®Google Scholar
• Eto K, Suga S, Wakui M et al. NADH shuttle system regulates K(ATP) channel-dependent pathway and steps distal to cytosolic Ca(2+) concentration elevation in glucose-induced insulin secretion. J. Biol. Chem.274(36), 25386–25392 (1999).
   PubMedGoogle Scholar
• Corkey BE, Glennon MC, Chen KS, Deeney JT, Matschinsky FM, Prentki M. A role for malonyl-CoA in glucose-stimulated insulin secretion from clonal pancreatic β-cells. J. Biol. Chem.264(36), 21608–21612 (1989).
   PubMed Web of Science ®Google Scholar
• Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion. J. Biol. Chem.267(9), 5802–5810 (1992).
   PubMed Web of Science ®Google Scholar
• MacDonald MJ, Fahien LA, Brown LJ, Hasan NM, Buss JD, Kendrick MA. Perspective: emerging evidence for signaling roles of mitochondrial anaplerotic products in insulin secretion. Am. J. Physiol. Endocrinol. Metab.288(1), E1–E15 (2005).
   PubMedGoogle Scholar
• Ronnebaum SM, Ilkayeva O, Burgess SC et al. A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J. Biol. Chem.281(41), 30593–30602 (2006).
   PubMedGoogle Scholar
• Henquin JC, Nenquin M, Stiernet P, Ahren B. In vivo and in vitro glucose-induced biphasic insulin secretion in the mouse: pattern and role of cytoplasmic Ca2+ and amplification signals in β-cells. Diabetes55(2), 441–451 (2006).
   PubMedGoogle Scholar
• MacDonald MJ, McKenzie DI, Walker TM, Kaysen JH. Lack of glyconeogenesis in pancreatic islets: expression of gluconeogenic enzyme genes in islets. Horm. Metab. Res.24(4), 158–160 (1992).
   PubMedGoogle Scholar
• Sekine N, Cirulli V, Regazzi R et al. Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic β-cells. Potential role in nutrient sensing. J. Biol. Chem.269(7), 4895–4902 (1994).
   PubMed Web of Science ®Google Scholar
• MacDonald MJ. Feasibility of a mitochondrial pyruvate malate shuttle in pancreatic islets. Further implication of cytosolic NADPH in insulin secretion. J. Biol. Chem.270(34), 20051–20058 (1995).
   PubMed Web of Science ®Google Scholar
• Bavamian S, Klee P, Britan A et al. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes. Metab.9(Suppl. 2), 118–132 (2007).
   PubMedGoogle Scholar
• De Leon DD, Stanley CA. Mechanisms of disease: advances in diagnosis and treatment of hyperinsulinism in neonates. Nat. Clin. Pract. Endocrinol. Metab.3(1), 57–68 (2007).
   PubMedGoogle Scholar
• Stanley CA, Lieu YK, Hsu BY et al. Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene. N. Engl. J. Med.338(19), 1352–1357 (1998).
   PubMed Web of Science ®Google Scholar
• Glaser B, Kesavan P, Heyman M et al. Familial hyperinsulinism caused by an activating glucokinase mutation. N. Engl. J. Med.338(4), 226–230 (1998).
   PubMed Web of Science ®Google Scholar
• Clayton PT, Eaton S, Aynsley-Green A et al. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. J. Clin. Invest.108(3), 457–465 (2001).
   PubMed Web of Science ®Google Scholar
• Molven A, Matre GE, Duran M et al. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes53(1), 221–227 (2004).
   PubMedGoogle Scholar
• Otonkoski T, Jiao H, Kaminen-Ahola N et al. Physical exercise-induced hypoglycemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic β cells. Am. J. Hum. Genet.81(3), 467–474 (2007).
   PubMedGoogle Scholar
• Otonkoski T, Kaminen N, Ustinov J et al. Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release. Diabetes52(1), 199–204 (2003).
   PubMedGoogle Scholar
• Goossens A, Gepts W, Saudubray JM et al. Diffuse and focal nesidioblastosis. A clinicopathological study of 24 patients with persistent neonatal hyperinsulinemic hypoglycemia. Am. J. Surg. Pathol.13(9), 766–775 (1989).
   PubMedGoogle Scholar
• Yakovac WC, Baker L, Hummeler K. β-cell nesidioblastosis in idiopathic hypoglycemia of infancy. J. Pediatr.79(2), 226–231 (1971).
   PubMed Web of Science ®Google Scholar
• Sempoux C, Guiot Y, Dubois D et al. Pancreatic β-cell proliferation in persistent hyperinsulinemic hypoglycemia of infancy: an immunohistochemical study of 18 cases. Mod. Pathol.11(5), 444–449 (1998).
   PubMedGoogle Scholar
• Service FJ, Natt N, Thompson GB et al. Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes. J. Clin. Endocrinol. Metab.84(5), 1582–1589 (1999).
   PubMedGoogle Scholar
• Patti ME, McMahon G, Mun EC et al. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia48(11), 2236–2240 (2005).
   PubMedGoogle Scholar
• Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N. Engl. J. Med.353(3), 249–254 (2005).
   PubMed Web of Science ®Google Scholar
• Meier JJ, Butler AE, Galasso R, Butler PC. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased β-cell turnover. Diabetes Care29(7), 1554–1559 (2006).
   PubMedGoogle Scholar
• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in humans with Type 2 diabetes. Diabetes52(1), 102–110 (2003).
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S, Weir GC. New sources of pancreatic β-cells. Nat. Biotechnol.23(7), 857–861 (2005).
   PubMed Web of Science ®Google Scholar
• Meier JJ, Butler AE, Saisho Y et al. β-cell replication is the primary mechanism subserving the postnatal expansion of β-cell mass in humans. Diabetes57(6), 1584–1594 (2008).
   PubMed Web of Science ®Google Scholar
• Brelje TC, Scharp DW, Lacy PE et al. Effect of homologous placental lactogens, prolactins, and growth hormones on islet β-cell division and insulin secretion in rat, mouse, and human islets: implication for placental lactogen regulation of islet function during pregnancy. Endocrinology132(2), 879–887 (1993).
   PubMed Web of Science ®Google Scholar
• Van Assche FA, Aerts L, De Prins F. A morphological study of the endocrine pancreas in human pregnancy. Br. J. Obstet. Gynaecol.85(11), 818–820 (1978).
   PubMedGoogle Scholar
• Ritzel RA, Butler AE, Rizza RA, Veldhuis JD, Butler PC. Relationship between β-cell mass and fasting blood glucose concentration in humans. Diabetes Care29(3), 717–718 (2006).
   PubMed Web of Science ®Google Scholar
• Georgia S, Bhushan A. β-cell replication is the primary mechanism for maintaining postnatal β cell mass. J. Clin. Invest.114(7), 963–968 (2004).
   PubMed Web of Science ®Google Scholar
• Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature429(6987), 41–46 (2004).
   PubMed Web of Science ®Google Scholar
• Alonso LC, Yokoe T, Zhang P et al. Glucose infusion in mice: a new model to induce β-cell replication. Diabetes56(7), 1792–1801 (2007).
   PubMed Web of Science ®Google Scholar
• Bonner-Weir S, Deery D, Leahy JL, Weir GC. Compensatory growth of pancreatic β-cells in adult rats after short-term glucose infusion. Diabetes38(1), 49–53 (1989).
   PubMed Web of Science ®Google Scholar
• Chick WL. β cell replication in rat pancreatic monolayer cultures. Effects of glucose, tolbutamide, glucocorticoid, growth hormone and glucagon 1. Diabetes22(9), 687–693 (1973).
   PubMedGoogle Scholar
• Ueki K, Okada T, Hu J et al. Total insulin and IGF-I resistance in pancreatic β cells causes overt diabetes. Nat. Genet.38(5), 583–588 (2006).
   PubMedGoogle Scholar
• Perfetti R, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology141(12), 4600–4605 (2000).
   PubMed Web of Science ®Google Scholar
• Withers DJ, Gutierrez JS, Towery H et al. Disruption of IRS-2 causes Type 2 diabetes in mice. Nature391(6670), 900–904 (1998).
   PubMed Web of Science ®Google Scholar
• Kushner JA, Ye J, Schubert M et al. Pdx1 restores β-cell function in Irs2 knockout mice. J. Clin. Invest.109(9), 1193–1201 (2002).
   PubMedGoogle Scholar
• Terauchi Y, Takamoto I, Kubota N et al. Glucokinase and IRS-2 are required for compensatory β-cell hyperplasia in response to high-fat diet-induced insulin resistance. J. Clin. Invest.117(1), 246–257 (2007).
   PubMed Web of Science ®Google Scholar
• Jhala US, Canettieri G, Screaton RA et al. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2. Genes Dev.17(13), 1575–1580 (2003).
   PubMed Web of Science ®Google Scholar
• Lingohr MK, Briaud I, Dickson LM et al. Specific regulation of IRS-2 expression by glucose in rat primary pancreatic islet β-cells. J. Biol. Chem.281(23), 15884–15892 (2006).
   PubMedGoogle Scholar
• Screaton RA, Conkright MD, Katoh Y et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell119(1), 61–74 (2004).
   PubMed Web of Science ®Google Scholar
• Tuttle RL, Gill NS, Pugh W et al. Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nat. Med.7(10), 1133–1137 (2001).
   PubMed Web of Science ®Google Scholar
• Bernal-Mizrachi E, Wen W, Stahlhut S, Welling CM, Permutt MA. Islet β cell expression of constitutively active Akt1/PKB α induces striking hypertrophy, hyperplasia, and hyperinsulinemia. J. Clin. Invest.108(11), 1631–1638 (2001).
   PubMed Web of Science ®Google Scholar
• Kitamura T, Nakae J, Kitamura Y et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J. Clin. Invest.110(12), 1839–1847 (2002).
   PubMed Web of Science ®Google Scholar
• Uchida T, Nakamura T, Hashimoto N et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med.11(2), 175–182 (2005).
   PubMed Web of Science ®Google Scholar
• Tanabe K, Liu Z, Patel S et al. Genetic deficiency of glycogen synthase kinase-3β corrects diabetes in mouse models of insulin resistance. PLoS Biol.6(2), e37 (2008).
   PubMed Web of Science ®Google Scholar
• Pende M, Kozma SC, Jaquet M et al. Hypoinsulinaemia, glucose intolerance and diminished β-cell size in S6K1-deficient mice. Nature408(6815), 994–997 (2000).
   PubMed Web of Science ®Google Scholar
• Alliouachene S, Tuttle RL, Boumard S et al. Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formation. J. Clin. Invest.118(11), 3629–3638 (2008).
   PubMedGoogle Scholar
• Johnson JD, Bernal-Mizrachi E, Alejandro EU et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc. Natl Acad. Sci. USA103(51), 19575–19580 (2006).
   PubMed Web of Science ®Google Scholar
• Elghazi L, Rachdi L, Weiss AJ, Cras-Meneur C, Bernal-Mizrachi E. Regulation of β-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes. Metab.9(Suppl. 2), 147–157 (2007).
   PubMed Web of Science ®Google Scholar
• Steiner DF, Oyer PE. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc. Natl Acad. Sci. USA57(2), 473–480 (1967).
   PubMed Web of Science ®Google Scholar
• Rhodes CJ. Diabetes mellitus In: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky JM,(Eds). Lippincott Williams & Wilkins, PA, USA 27–50 (2004).
   Google Scholar
• Orci L, Ravazzola M, Storch MJ, Anderson RG, Vassalli JD, Perrelet A. Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated secretory vesicles. Cell49(6), 865–868 (1987).
   PubMed Web of Science ®Google Scholar
• Davidson HW, Rhodes CJ, Hutton JC. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β cell via two distinct site-specific endopeptidases. Nature333(6168), 93–96 (1988).
   PubMed Web of Science ®Google Scholar
• Smeekens SP, Montag AG, Thomas G et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc. Natl Acad. Sci. USA89(18), 8822–8826 (1992).
   PubMedGoogle Scholar
• Davidson HW, Hutton JC. The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem. J.245(2), 575–582 (1987).
   PubMed Web of Science ®Google Scholar
• Roth J, Gorden P, Pastan I. “Big insulin”: a new component of plasma insulin detected by immunoassay. Proc. Natl Acad. Sci. USA61(1), 138–145 (1968).
   PubMed Web of Science ®Google Scholar
• Lazarus NR, Tanese T, Gutman R, Recant L. Synthesis and release of proinsulin and insulin by human insulinoma tissue. J. Clin. Endocrinol. Metab.30(3), 273–281 (1970).
   PubMed Web of Science ®Google Scholar
• Gorden P, Sherman B, Roth J. Proinsulin-like component of circulating insulin in the basal state and in patients and hamsters with islet cell tumors. J. Clin. Invest.50(10), 2113–2122 (1971).
   PubMed Web of Science ®Google Scholar
• Gutman RA, Lazarus NR, Penhos JC, Fajans S, Recant L. Circulating proinsulin-like material in patients with functioning insulinomas. N. Engl. J. Med.284(18), 1003–1008 (1971).
   PubMed Web of Science ®Google Scholar
• Sherman BM, Pek S, Fajans SS, Floyd JC Jr, Conn JW. Plasma proinsulin in patients with functioning pancreatic islet cell tumors. J. Clin. Endocrinol. Metab.35(2), 271–280 (1972).
   PubMedGoogle Scholar
• Gorden P, Skarulis MC, Roach P et al. Plasma proinsulin-like component in insulinoma: a 25-year experience. J. Clin. Endocrinol. Metab.80(10), 2884–2887 (1995).
   PubMedGoogle Scholar
• Halban PA, Irminger JC. Sorting and processing of secretory proteins. Biochem. J.299(Pt 1), 1–18 (1994).
   PubMedGoogle Scholar
• Irminger JC, Vollenweider FM, Neerman-Arbez M, Halban PA. Human proinsulin conversion in the regulated and the constitutive pathways of transfected AtT20 cells. J. Biol. Chem.269(3), 1756–1762 (1994).
   PubMedGoogle Scholar
• Nagamatsu S, Steiner DF. Altered glucose regulation of insulin biosynthesis in insulinoma cells: mouse β TC3 cells secrete insulin-related peptides predominantly via a constitutive pathway. Endocrinology130(2), 748–754 (1992).
   PubMedGoogle Scholar
• Kao PC, Taylor RL, Service FJ. Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma. J. Clin. Endocrinol. Metab.78(5), 1048–1051 (1994).
   PubMedGoogle Scholar
• Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clin. Proc.66(7), 711–719 (1991).
   PubMed Web of Science ®Google Scholar
• Marx S, Spiegel AM, Skarulis MC, Doppman JL, Collins FS, Liotta LA. Multiple endocrine neoplasia type 1: clinical and genetic topics. Ann. Intern. Med.129(6), 484–494 (1998).
   PubMed Web of Science ®Google Scholar
• Anlauf M, Bauersfeld J, Raffel A et al. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. Am. J. Surg. Pathol.33(3) (2009).
   PubMedGoogle Scholar
• Anlauf M, Schlenger R, Perren A et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am. J. Surg. Pathol.30(5), 560–574 (2006).
   PubMed Web of Science ®Google Scholar
• Guettier JM, Kam A, Chang R et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience. J. Clin. Endocrinol. Metab.94(4), 1074–1080 (2009).
   PubMed Web of Science ®Google Scholar
• Hirshberg B, Livi A, Bartlett DL et al. Forty-eight-hour fast: the diagnostic test for insulinoma. J. Clin. Endocrinol. Metab.85(9), 3222–3226 (2000).
   PubMed Web of Science ®Google Scholar
• Hirshberg B, Cochran C, Skarulis MC et al. Malignant insulinoma: spectrum of unusual clinical features. Cancer104(2), 264–272 (2005).
   PubMed Web of Science ®Google Scholar
• Guettier JM, Gorden P. Hypoglycemia. Endocrinol. Metab. Clin. North Am.35(4), 753ix–757ix (2006).
   Google Scholar
• Marx SJ, Simonds WF. Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocr. Rev.26(5), 615–661 (2005).
   PubMedGoogle Scholar
• Perren A, Roth J, Muletta-Feurer S et al. Clonal analysis of sporadic pancreatic endocrine tumours. J. Pathol.186(4), 363–371 (1998).
   PubMedGoogle Scholar
• Barghorn A, Komminoth P, Bachmann D et al. Deletion at 3p25.3–p23 is frequently encountered in endocrine pancreatic tumours and is associated with metastatic progression. J. Pathol.194(4), 451–458 (2001).
   PubMedGoogle Scholar
• Barghorn A, Speel EJ, Farspour B et al. Putative tumor suppressor loci at 6q22 and 6q23–q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am. J. Pathol.158(6), 1903–1911 (2001).
   PubMedGoogle Scholar
• Speel EJ, Richter J, Moch H et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am. J. Pathol.155(6), 1787–1794 (1999).
   PubMed Web of Science ®Google Scholar
• Zhao J, Moch H, Scheidweiler AF et al. Genomic imbalances in the progression of endocrine pancreatic tumors. Genes Chromosomes Cancer32(4), 364–372 (2001).
   PubMed Web of Science ®Google Scholar
• Jonkers YM, Claessen SM, Perren A et al. Chromosomal instability predicts metastatic disease in patients with insulinomas. Endocr. Relat. Cancer12(2), 435–447 (2005).
   PubMed Web of Science ®Google Scholar
• Zhuang Z, Vortmeyer AO, Pack S et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res.57(21), 4682–4686 (1997).
   PubMed Web of Science ®Google Scholar
• Arnold CN, Sosnowski A, Schmitt-Graff A, Arnold R, Blum HE. Analysis of molecular pathways in sporadic neuroendocrine tumors of the gastro–entero–pancreatic system. Int. J. Cancer120(10), 2157–2164 (2007).
   PubMed Web of Science ®Google Scholar
• Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in β cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell109(3), 321–334 (2002).
   PubMed Web of Science ®Google Scholar
• Creutzfeldt W, Creutzfeldt C, Frerichs H, Track NS, Arnold R. Histochemistry, ultrastructure and hormone content of human insulinomas. Horm. Metab. Res. (Suppl. 6), 7–18 (1976).
   PubMedGoogle Scholar
• Minn AH, Kayton M, Lorang D et al. Insulinomas and expression of an insulin splice varient. Lancet363(9406), 363–373 (2004).
   PubMedGoogle Scholar
• Placzkowski KA, Vella A, Thompson GB et al. Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987–2007. J. Clin. Endocrinol. Metab.94(4), 1069–1073 (2009).
   PubMed Web of Science ®Google Scholar
• Brown CK, Bartlett DL, Doppman JL et al. Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas. Surgery122(6), 1189–1193 (1997).
   PubMed Web of Science ®Google Scholar
• Pitre J, Soubrane O, Palazzo L, Chapuis Y. Endoscopic ultrasonography for the preoperative localization of insulinomas. Pancreas13(1), 55–60 (1996).
   PubMedGoogle Scholar
• Schumacher B, Lubke HJ, Frieling T, Strohmeyer G, Starke AA. Prospective study on the detection of insulinomas by endoscopic ultrasonography. Endoscopy28(3), 273–276 (1996).
   PubMedGoogle Scholar
• Ardengh JC, Rosenbaum P, Ganc AT et al. Role of EUS in the preoperative localization of insulinomas compared with spiral CT. Gastrointest. Endosc.51(5), 552–555 (2000).
   PubMedGoogle Scholar
• Nesje LB, Varhaug JE, Husebye ES, Odegaard S. Endoscopic ultrasonography for preoperative diagnosis and localization of insulinomas. Scand. J. Gastroenterol.37(6), 732–737 (2002).
   PubMed Web of Science ®Google Scholar
• Zimmer T, Stolzel U, Bader M et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut39(4), 562–568 (1996).
   PubMed Web of Science ®Google Scholar
• Krenning EP, Kwekkeboom DJ, Oei HY et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results. Ann. NY Acad. Sci.733, 416–424 (1994).
   PubMedGoogle Scholar
• van Eyck CH, Bruining HA, Reubi JC et al. Use of isotope-labeled somatostatin analogs for visualization of islet cell tumors. World J. Surg.17(4), 444–447 (1993).
   PubMedGoogle Scholar
• Oberg K, Astrup L, Eriksson B et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I – general overview. Acta Oncol.43(7), 617–625 (2004).
   PubMed Web of Science ®Google Scholar
• Oberg K. Somatostatin analog octreotide LAR in gastro–entero–pancreatic tumors. Expert Rev. Anticancer. Ther.9(5), 557–566 (2009).
   PubMed Web of Science ®Google Scholar
• Kauhanen S, Seppanen M, Minn H et al. Fluorine-18-l-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients. J. Clin. Endocrinol. Metab.92(4), 1237–1244 (2007).
   PubMed Web of Science ®Google Scholar
• Wild D, Macke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N. Engl. J. Med.359(7), 766–768 (2008).
   PubMed Web of Science ®Google Scholar